Glucose Health, Inc.
GLUCOTCConsumer Defensive● Active
$0.46
+$0.02(+4.55%)
Market Cap$7825520
P/E Ratio—
52W High$0.674
52W Low$0.02
Glucose Health, Inc. (GLUC) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
GLUC · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 15, 2026EPS Actual
-$0.01
Revenue
—
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 15, 2026
After Market Close
GLUC reports quarterly as a OTC-listed Packaged Foods company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$3.83
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$3.83
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q2 FY2026 | May 15, 2026 | — | -$0.01 | — | — | — | — |
| — Q4 FY2025 | Oct 17, 2025 | — | -$0.01 | — | $0.00B | — | — |
| — Q3 FY2025 | Aug 8, 2025 | — | -$0.01 | — | — | — | — |
| — Q1 FY2025 | Jan 31, 2025 | — | -$0.00 | — | $0.00B | — | — |
| — Q4 FY2024 | Nov 8, 2024 | — | -$0.01 | — | $0.00B | — | — |
| — Q2 FY2024 | Jun 29, 2024 | — | -$0.01 | — | $0.00B | — | — |
| — Q2 FY2024 | May 10, 2024 | — | -$0.00 | — | $0.00B | — | — |
| — Q4 FY2023 | Dec 30, 2023 | — | -$0.01 | — | $0.00B | — | — |
Q2 FY2026
May 15, 2026
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2025
Oct 17, 2025
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2025
Aug 8, 2025
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2025
Jan 31, 2025
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2024
Nov 8, 2024
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2024
Jun 29, 2024
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2024
May 10, 2024
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2023
Dec 30, 2023
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
No analyst estimates available for GLUC.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2026 | May 15, 2026 | — | $0.32 | $0.32 | +0.00% |
| — Q4 FY2025 | Oct 17, 2025 | — | $0.04 | $0.04 | -0.14% |
| — Q3 FY2025 | Aug 8, 2025 | — | $0.10 | $0.09 | -9.90% |
| — Q1 FY2025 | Jan 31, 2025 | — | $0.14 | $0.12 | -15.00% |
| — Q4 FY2024 | Nov 8, 2024 | — | $0.20 | $0.20 | +0.00% |
| — Q2 FY2024 | Jun 29, 2024 | — | $0.35 | $0.35 | +0.00% |
| — Q2 FY2024 | May 10, 2024 | — | $0.40 | $0.38 | -5.08% |
| — Q4 FY2023 | Dec 30, 2023 | — | $0.28 | $0.34 | +21.52% |
Q2 FY2026+0.00%
Report Date
May 15, 2026
EPS Beat/Miss
—
Price Before
$0.32
Price After
$0.32
Q4 FY2025-0.14%
Report Date
Oct 17, 2025
EPS Beat/Miss
—
Price Before
$0.04
Price After
$0.04
Q3 FY2025-9.90%
Report Date
Aug 8, 2025
EPS Beat/Miss
—
Price Before
$0.10
Price After
$0.09
Q1 FY2025-15.00%
Report Date
Jan 31, 2025
EPS Beat/Miss
—
Price Before
$0.14
Price After
$0.12
Q4 FY2024+0.00%
Report Date
Nov 8, 2024
EPS Beat/Miss
—
Price Before
$0.20
Price After
$0.20
Q2 FY2024+0.00%
Report Date
Jun 29, 2024
EPS Beat/Miss
—
Price Before
$0.35
Price After
$0.35
Q2 FY2024-5.08%
Report Date
May 10, 2024
EPS Beat/Miss
—
Price Before
$0.40
Price After
$0.38
Q4 FY2023+21.52%
Report Date
Dec 30, 2023
EPS Beat/Miss
—
Price Before
$0.28
Price After
$0.34
Beat Rate0 / 8 quarters
Largest Move+21.52% (Q4 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: GLUC ends December
Glucose Health, Inc. (GLUC) most recently reported earnings on May 15, 2026 for Q2 FY2026, posting EPS of $-0.01 (in line with the analyst consensus of —). The next GLUC earnings date is expected around September 1, 2026.
Each quarter, investors track GLUC earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. GLUC revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
GLUC's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
GLUC earnings · 4 questionsGlucose Health, Inc.'s next earnings report is expected around September 1, 2026. GLUC typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; GLUC historically reports after market close (AMC).
GLUC earnings datewhen is GLUC earningsGLUC next earnings datewhen does GLUC report earningsGLUC earnings calendar
▸ Source: FMP · Glucose Health, Inc. SEC filings · US GAAP · Glucose Health, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026